NCT02032563View on ClinicalTrials.gov

Study of the ICG Distribution in Breast Tumours or in Axillary Lymph Nodes of Patients After Neoadjuvant Therapy

PHASE2UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Breast Cancer
Interventions
DRUG

Indocyanine Green

intravenous injection of 0.25mg/kg Indocyanine Green just before the surgery

Trial Locations (1)

1000

RECRUITING

Jules Bordet Institute, Brussels

Sponsors
All Listed Sponsors
lead

Jules Bordet Institute

OTHER